Preventive Cancer Stem Cell-Based Vaccination Reduces Liver Metastasis Development in a Rat Colon Carcinoma Syngeneic Model

The Ischemia-Responsive Protein 94 (Irp94) Activates Dendritic Cells through NK Cell Receptor Protein-2/NK Group 2 Member D (NKR-P2/NKG2D) Leading to Their Maturation

(2014) R. M. Srivastava et al.   JOURNAL OF IMMUNOLOGY

Cancer Stem Cell Vaccination Confers Significant Antitumor Immunity

(2012) N. Ning et al.   CANCER RESEARCH

Targeting Aldose Reductase for the Treatment of Cancer

(2012) R. Tammali et al.   CURRENT CANCER DRUG TARGETS

Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells

(2012) Yucui Dong et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Proliferation State and Polo-Like Kinase1 Dependence of Tumorigenic Colon Cancer Cells

(2012) Federica Francescangeli et al.   STEM CELLS

Involvement of the aldo–keto reductase, AKR1B10, in mitomycin-c resistance through reactive oxygen species-dependent mechanisms

(2011) Toshiyuki Matsunaga et al.   ANTI-CANCER DRUGS

Inhibition of aldose reductase prevents colon cancer metastasis

(2011) Ravinder Tammali et al.   CARCINOGENESIS

Aldose Reductase Inhibition Prevents Hypoxia-induced Increase in Hypoxia-inducible Factor-1α (HIF-1α) and Vascular Endothelial Growth Factor (VEGF) by Regulating 26 S Proteasome-mediated Protein Degradation in Human Colon Cancer Cells

(2011) Ravinder Tammali et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Selection of putative colorectal cancer markers by applying PCA on the soluble proteome of tumors: NDK A as a promising candidate

(2011) Paula Álvarez-Chaver et al.   Journal of Proteomics

Identification of phosphorylated serine-15 and -82 residues of HSPB1 in 5-fluorouracil-resistant colorectal cancer cells by proteomics

(2011) Akiko Sakai et al.   Journal of Proteomics

Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer

(2011) Feng Wang et al.   MEDICAL ONCOLOGY

Immunoproteomics of HER2-Positive and HER2-Negative Breast Cancer Patients with Positive Lymph Nodes

(2011) Zahra Mojtahedi et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma

(2011) Michael P. Kim et al.   PLoS One

Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27

(2010) Han-Shui Hsu et al.   CANCER

Proteomic analysis of cell lines to identify the irinotecan resistance proteins

(2010) Xing-Chen Peng et al.   JOURNAL OF BIOSCIENCES

Genome-Wide mRNA and microRNA Profiling of the NCI 60 Cell-Line Screen and Comparison of FdUMP[10] with Fluorouracil, Floxuridine, and Topoisomerase 1 Poisons

(2010) W. H. Gmeiner et al.   MOLECULAR CANCER THERAPEUTICS

Distinct Expression Levels and Patterns of Stem Cell Marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in Human Epithelial Cancers

(2010) Shan Deng et al.   PLoS One

Whole tumor antigen vaccines

(2010) Cheryl Lai-Lai Chiang et al.   SEMINARS IN IMMUNOLOGY

Combination of aging and dimethylhydrazine treatment causes an increase in cancer—stem cell population of rat colonic crypts

(2009) Edi Levi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Comparative proteomic analysis of colon cancer cells in response to Oxaliplatin treatment

(2009) Yi Yao et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis

(2009) E. H. Huang et al.   CANCER RESEARCH

DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders

(2009) Philipp J. Kahle et al.   FREE RADICAL BIOLOGY AND MEDICINE

Optimization of Dendritic Cell Loading With Tumor Cell Lysates for Cancer Immunotherapy

(2009) Paul Hatfield et al.   JOURNAL OF IMMUNOTHERAPY

Association of reactive oxygen species levels and radioresistance in cancer stem cells

(2009) Maximilian Diehn et al.   NATURE

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

(2009) Dunyaporn Trachootham et al.   NATURE REVIEWS DRUG DISCOVERY

Proteome Serological Determination of Tumor-Associated Antigens in Melanoma

(2009) Michael Forgber et al.   PLoS One

Identification of distinctive protein expression patterns in colorectal adenoma

(2009) Francis F. Lam et al.   Proteomics Clinical Applications

STAT3 Is Required for Proliferation and Maintenance of Multipotency in Glioblastoma Stem Cells

(2009) Maureen M. Sherry et al.   STEM CELLS

Current management of colorectal hepatic metastasis

(2009) Skye C Mayo et al.   Expert Review of Gastroenterology & Hepatology

Vascular determinants of cancer stem cell dormancy-do age and coagulation system play a role? 

(2008) JANUSZ RAK et al.   APMIS

The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide

(2008) M. Bacolod et al.   CURRENT CANCER DRUG TARGETS

Characterization of a subpopulation of colon cancer cells with stem cell-like properties

(2008) Peter Chu et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

(2008) Kyeung Min Joo et al.   LABORATORY INVESTIGATION

Efficient tumour formation by single human melanoma cells

(2008) Elsa Quintana et al.   NATURE

IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS

(2008) Alfred T. Ogden et al.   NEUROSURGERY

Teratoma Formation by Human Embryonic Stem Cells Is Site Dependent and Enhanced by the Presence of Matrigel

(2008) Tatyana A. Prokhorova et al.   STEM CELLS AND DEVELOPMENT

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

(2007) Jian Wang et al.   INTERNATIONAL JOURNAL OF CANCER